Geoff, I am genuinely interested in learning more in order to help people who are vaccine injured. I was excited to read your interview, and to learn more about this supplement situation. I have no 'covid heroes,' I'm just looking for answers.
TWC is flogging very high priced pills for Spikeopathy, so you would expect a registered clinical trial to find evidence of efficacy and close recording of any Adverse Events.
I read an article from 2008 where scientists gave mice ivermectin and a lethal dose of lipopolysaccharide (LPS)- an endotoxin to investigate whether ivermectin, a semi-synthetic derivative of a family of macrocyclic lactones could inhibit lipopolysaccharide (LPS)-induced inflammation in vivo and in vitro. Quotes. from the articles:
"Ivermectin improved mouse survival rate induced by a lethal dose of LPS. In addition, ivermectin significantly decreased the production of TNF-alpha, IL-1ss and IL-6 in vivo and in vitro. Furthermore, ivermectin suppressed NF-kB translocation induced by LPS.
ivermectin may inhibit LPS-induced production of inflammatory cytokines by blocking NF-kB pathway and improve LPS-induced survival in mice. This finding might provide a new strategy for the treatment of endotoxemia and associated inflammation."
Geoff, I am genuinely interested in learning more in order to help people who are vaccine injured. I was excited to read your interview, and to learn more about this supplement situation. I have no 'covid heroes,' I'm just looking for answers.
Anyway, best wishes.
TWC is flogging very high priced pills for Spikeopathy, so you would expect a registered clinical trial to find evidence of efficacy and close recording of any Adverse Events.
That is absolutely crazy that there is no clinical trial or adverse events reporting system.
They appear to be 'moving at the speed of science.'
I read an article from 2008 where scientists gave mice ivermectin and a lethal dose of lipopolysaccharide (LPS)- an endotoxin to investigate whether ivermectin, a semi-synthetic derivative of a family of macrocyclic lactones could inhibit lipopolysaccharide (LPS)-induced inflammation in vivo and in vitro. Quotes. from the articles:
"Ivermectin improved mouse survival rate induced by a lethal dose of LPS. In addition, ivermectin significantly decreased the production of TNF-alpha, IL-1ss and IL-6 in vivo and in vitro. Furthermore, ivermectin suppressed NF-kB translocation induced by LPS.
ivermectin may inhibit LPS-induced production of inflammatory cytokines by blocking NF-kB pathway and improve LPS-induced survival in mice. This finding might provide a new strategy for the treatment of endotoxemia and associated inflammation."
https://link.springer.com/article/10.1007/s00011-008-8007-8
https://pubmed.ncbi.nlm.nih.gov/19109745/